key: cord-1024865-9m78yz0u
authors: Gao, Feng; Huang, Zhi-Ming
title: The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research
date: 2020-06-20
journal: J Hepatol
DOI: 10.1016/j.jhep.2020.06.024
sha: c2f1367ed6e1c0a0e5af0e8357ca5c8878e3a26e
doc_id: 1024865
cord_uid: 9m78yz0u

nan

We read with interest the paper "High rates of 30-day mortality in patients with cirrhosis and COVID-19" by Massimo et al. in Journal of Hepatology. [1] In the article, the authors report COVID-19 is associated with elevated 30-day mortality in cirrhotic patients. After carefully reading, we wish to put forth the following suggestions.

First, there were four predictor variables (MELD, delta-MELD, CLIF-OF, and moderate/severe respiratory failure) with 17 fatal outcome events in the multivariate Cox model. The rule of thumb that logistic and Cox models should be used with a minimum of 10 events per predictor variable (EPV). Previous results showed increasing bias and variability, unreliable confidence interval coverage, and problems with model convergence as EPV declined below 10 and especially below five [2, 3] .

Therefore, a larger sample size cohort is needed to validate the results of this study.

Second, it might be reasonable to use logistic regression, with the outcome being a dichotomous status (alive or dead) since the relative granularity of time is low (a short-term follow-up: 30 days). Third, the authors report that patients with cirrhosis generation. [4, 5] Experimentally, Ang-(1-7) inhibits liver fibrogenesis and exerts natriuretic and portal hypotensive effects. [6] The reduction in ACE2 by SARS-CoV-2-induced internalization would be predicted to aggravate liver fibrosis and portal hypertension, and exacerbate disease severity, especially, in the long-term.

Therefore, the impact of COVID-19 on the long-term liver related outcome of patients with cirrhosis deserves attention.

High rates of 30-day mortality in patients with cirrhosis and COVID-19

Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy

Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates

COVID-19, ACE2, and the cardiovascular consequences

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver disease